
Thursday, November 24, 2022 4:20:32 PM
"We distill from these hypotheticals three requisites
for proving harm: (1) a substantiated desire by the
President to remove the unconstitutionally insulated ac-
tor, (2) a perceived inability to remove the actor due to
the infirm provision, and (3) a nexus between the desire
to remove and the challenged actions taken by the insu-
lated actor. This is borne out by the concurring Jus-
tices’ opinions as well. See id. at 1792-93 (Thomas, J.,
concurring); id. at 1801 (Kagan, J., concurring in part);
id. at 1803 n.1 (Sotomayor, J., concurring in part and dissenting in part). As Justice Kagan emphasized,
“plaintiffs alleging a removal violation are entitled to in-
junctive relief—a rewinding of agency action—only
when the President’s inability to fire an agency head af-
fected the complained-of decision.” Id. at 1801 (Ka-
gan, J., concurring in part) (emphasis added).
It is thus not enough, as the Plaintiffs would have us
hold, for a challenger to obtain relief merely by estab-
lishing that the unconstitutional removal provision pre-
vented the President from removing a Director he
wished to replace. As we read Collins, to demonstrate
harm, the Plaintiffs must show a connection between
the President’s frustrated desire to remove the actor
and the agency action complained of. See id. at 1789.
Without this showing, the Plaintiffs could put them-
selves in a better place than otherwise warranted, by
challenging decisions either with which the President
agreed, or of which he had no awareness at all. Id. at
1802 (Kagan, J., concurring in part)."

Liked By
Spread the love. Be the first to like this post!
Recent FNMA News
- Mortgage Rates Fall Amid Volatile Activity • Dow Jones News • 01/12/2023 05:30:00 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 12/14/2022 09:56:53 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/05/2022 02:19:59 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:11:00 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:10:55 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:10:14 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:10:08 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:09:05 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:08:58 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:08:54 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:08:00 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:07:53 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:07:35 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:05:50 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:05:29 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:05:13 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:04:32 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/14/2022 11:02:17 AM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:29:41 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:25:27 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:23:23 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:19:30 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:14:02 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:12:30 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 11/10/2022 10:12:14 PM
FEATURED 1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM